News Daily News Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients Michael O'Riordan June 10, 2020
News Daily News YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50 L.A. McKeown June 04, 2020
News Opinion Off Script Off Script: Black Lives, COVID-19, Katrina, and Social Justice—Time for Healers to Step Up Keith C. Ferdinand June 02, 2020
News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
News Daily News US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable Shelley Wood May 29, 2020
News Daily News AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives Yael L. Maxwell May 29, 2020
News Daily News US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors L.A. McKeown May 28, 2020
News Daily News Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades Yael L. Maxwell May 28, 2020
News Daily News Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19 Michael O'Riordan May 26, 2020
News Daily News COVID-19 Autopsies Put Endothelial Damage, Angiogenesis in the Spotlight L.A. McKeown May 26, 2020
News Features Cardiology After COVID-19: Physicians Predict Lasting Change Yael L. Maxwell May 20, 2020
News Conference News SCAI 2020 Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data Caitlin E. Cox May 15, 2020
News Daily News Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans Michael O'Riordan May 15, 2020
News Daily News High-Intensity Sport Post-COVID: Expert Advice From Sports Cardiologists Caitlin E. Cox May 13, 2020
News Features Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes Michael O'Riordan May 12, 2020
News Daily News Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts Shelley Wood May 06, 2020
News Daily News Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated L.A. McKeown May 05, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020